secwatch.observer — SEC 8-K summary
======================================

Issuer:     STERIS plc (STE)
CIK:        0001757898
Form:       8-K
Filed at:   2026-10-13T20:29:56+00:00
Accession:  0001193125-26-420487
Event type: m_and_a
Sentiment:  positive
Materiality: 0.82
Item codes: 1.01
LLM model:  deepseek-v4.1-flash:cloud@v2

STERIS to acquire Xodus Medical for $2.1B cash, plus up to $150M earnout; $2.0B bridge committed
--------------------------------------------------------------------------------

- STERIS Corporation, a wholly owned subsidiary of STERIS plc, signed a Purchase and Sale Agreement on October 11, 2026 to buy all equity of Xodus Medical, Inc.
- Purchase price is $2.1B in cash at closing, subject to customary adjustments, plus up to $150M earnout tied to calendar 2028 performance targets.
- Sellers are Craig E. Kaforey and Mark A. Kaforey, individually and as trustees of their respective Legacy Trusts; Xodus is a Pennsylvania specialty surgical products business.
- Deal expected to close by December 31, 2026, subject to regulatory approvals; either party may terminate if not closed by July 12, 2027, extendable to January 11, 2028.
- Financing: up to $2.0B senior unsecured bridge facility committed by JPMorgan Chase Bank and Goldman Sachs Bank USA, reducible dollar-for-dollar by permanent financing or asset sale proceeds.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1757898/000119312526420487/0001193125-26-420487-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1757898/000119312526420487/d165776d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-420487

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer